SEIZERT CAPITAL PARTNERS, LLC - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 164 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SEIZERT CAPITAL PARTNERS, LLC ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$327,000
-10.4%
7,3700.0%0.02%0.0%
Q1 2022$365,000
-2.7%
7,3700.0%0.02%0.0%
Q4 2021$375,000
-60.6%
7,370
-62.9%
0.02%
-73.8%
Q2 2020$952,000
-10.6%
19,848
-14.2%
0.06%
-16.7%
Q1 2020$1,065,000
-29.6%
23,146
-8.1%
0.08%
+4.0%
Q4 2019$1,513,00025,1760.08%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 113,737$3,2270.98%
Smith, Graham & Co., Investment Advisors, LP 236,883$6,720,3710.82%
Capital Impact Advisors, LLC 13,607$386,0310.47%
TANG CAPITAL MANAGEMENT LLC 80,000$2,269,6000.34%
BRANDES INVESTMENT PARTNERS, LP 545,050$15,463,0690.33%
Watershed Asset Management, L.L.C. 9,496$269,4020.33%
Jackson Creek Investment Advisors LLC 25,164$7140.30%
SummerHaven Investment Management, LLC 18,178$515,7100.30%
Virtus Fund Advisers, LLC 1,117$31,6890.22%
Virtus Investment Advisers, Inc. 7,308$207,3280.14%
View complete list of EAGLE PHARMACEUTICALS INC shareholders